A burst of high quality pre-clinical candidates driven by AI platforms
AI driven Pipelines are supposed to be much more efficient: faster, cost effective, with better efficacy, less toxicities. AI platforms are also supposed to solve traditionally difficulty diseases, like metabolic disorders and age-related diseases.
Note that we can already manipulate the images in a way that smart enough for time-lapse changes, expressions, decorations and etc. Image that we also will be able to manipulate the small molecules toward the direction that the properties and activities are we wanted.
Nonalcoholic steatohepatitis (NASH) is a chronic, progressive disease characterized by hepatic steatosis, balloon-like changes, diffuse hepatic lobular mild inflammation, and etc.Learn more
WHO’s report in 2016 stated that nearly 2 billion adults worldwide were overweight and, of these, more than half a billion were obese. Obesity increased markedly over the past 4 decades.Learn more
Gout and hyperuricemia are purine metabolic disorders leading to abnormal accumulation of uric acid, causing inflammation as well as gouty arthritis and uric acid nephrolithiasis.Learn more
Aging is the major risk factor of many diseases, including cancer and Alzhimers' disease. It' characterized by a progressive decline in functional and physiological integrity.Learn more
Tendon injury is the major factor for an athlete to halt his / her career. The effective drug to accelerate the tendon healing is in urgent needs. It's a big challenge because of its complexity.Learn more
Cancers are fatal diseases. Target based pipelines have made progresses. We have perspective on the shoulder of AI. Combing with gene signatures would be ice-breaking.Learn more